H. Quasny

发表

Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison

S. Navarra, R. Furie, Fengchun Zhang, 2021, RMD Open.

P128 Efficacy of intravenous belimumab in children with systemic lupus erythematosus with markers of high disease activity: across-trial comparison with adult belimumab studies

A. Hammer, B. Ji, D. Bass, 2020 .

InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.

Meilan K. Han, F. Martinez, H. Watz, 2020, Chronic obstructive pulmonary diseases.

MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT

H. Noma, H. Quasny, R. Levy, 2022, Lupus Science & Medicine.

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

I. Bruce, M. Petri, M. Urowitz, 2022, Arthritis care & research.

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

F. Martinez, P. Calverley, B. Celli, 2020, American journal of respiratory and critical care medicine.

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

I. Bruce, M. Urowitz, Ming-hui Zhao, 2022, Lupus Science & Medicine.

Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data

A. Schwarting, D. Wallace, Fengchun Zhang, 2022, Lupus.

Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports

Kelsey M. Sumner, M. Petri, H. Tilson, 2022, Annals of the Rheumatic Diseases.

Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study

D. Chauhan, A. Richards, H. Quasny, 2022, Lupus Science & Medicine.

Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.

C. Bao, D. Chauhan, H. Quasny, 2023, Value in health regional issues.

Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia

S. Kwok, H. Quasny, Seung-Geun Lee, 2023, International journal of rheumatic diseases.